Identification of PSME3 as a Novel Serum Tumor Marker for Colorectal Cancer by Combining Two-dimensional Polyacrylamide Gel Electrophoresis with a Strictly Mass Spectrometry-based Approach for Data Analysis
Open Access
- 1 November 2006
- journal article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 5 (11), 2092-2101
- https://doi.org/10.1074/mcp.m600118-mcp200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Web‐based data warehouse on gene expression in human colorectal cancerProteomics, 2005
- Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitorsTrends in Cell Biology, 2005
- Clinical utility of biochemical markers in colorectal cancerEuropean Journal Of Cancer, 2003
- Drosophila Proteasome Regulator REGγ: Transcriptional Activation by DNA Replication-related Factor DREF and Evidence for a Role in Cell Cycle ProgressionJournal of Molecular Biology, 2003
- Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidenceGastroenterology, 2003
- Fuzzy logic-based tumor-marker profiles improved sensitivity in the diagnosis of lung cancerInternational Journal of Clinical Oncology, 2002
- Ubiquitin-mediated proteolysis: biological regulation via destructionBioEssays, 2000
- FECAL OCCULT BLOOD TESTING FOR COLORECTAL CANCER: Can We Afford to Do This?Gastroenterology Clinics of North America, 1997
- Loss in transformed cells of cell cycle regulation of expression of a nuclear protein recognized by SLE patient antiseraExperimental Cell Research, 1989
- Major complications of coloscopy: Bleeding and perforationDigestive Diseases and Sciences, 1975